Michael Webb

Assistant Professor

Chemistry

Office

Science Laboratory Building - SLB 205

Office Hours

Monday 11:30-12:30pm; Tuesday 9:00-10:00 am; Wednesday 10:30-11:30am; or by appointment.

Office Phone

(309) 438-8576office
phone

Department Phone

(309) 438-7661dept
phone

Fax

(309) 438-5538fax

miwebb@ilstu.eduemail

Website

webb-lab.weebly.com/website

About
Education
Research

Current Courses

140General Chemistry I

141General Chemistry II

299Independent Honor Study In Chemistry

499Independent Research For The Master's Thesis

290Research in Chemistry

490Research In Chemistry

Research Interests & Areas

Research within the Webb group focuses on the occurrence of metals in medicine, as either the therapeutic agent or the target for therapy. Specifically, protein interactions have been observed to be central in either the pathology of several diseases following an interaction with endogenous metal ions, thereby becoming the target for therapy, or in the transportation of metallotherapeutics to their site of action. We are currently investigating several metal-protein interactions, to provide new leads for therapeutic development. For more information on current research and potential opportunities, please visit my personal research webpage.

Post-Doc Bioengineering

University of California Berkeley

Berkeley, CA

Ph D Chemistry

Simon Fraser University

Burnaby, BC, Canada

BS Chemistry

Mount Allison University

Sackville, NB, Canada

Journal Article, Academic Journal

Webb, M., & Walsby, C. Albumin binding and ligand-exchange processes of the Ru(III) anticancer agent NAMI-A and its bis-DMSO analogue determined by ENDOR spectroscopy. Dalton Transactions 44 (2015): 17482-17493.

Jones, M., Mu, C., Wang, M., Webb, M., Walsby, C., & Storr, T. Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity. Metallomics 7 (2014): 129-135.